おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
SciNeuro
company
About
SciNeuro is a biotechnology company focused on developing innovative medicines for patients with central nervous system diseases.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $100M
- Industries
- Biopharma,Biotechnology,Neuroscience
- Founded date
- Jan 1, 2020
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$100M
SciNeuro has raised a total of
$100M
in funding over 2 rounds. Their latest funding was raised on
Dec 8, 2020 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 8, 2020 | Series A | $100M | 2 |
ARCH Venture Partners
Lilly Asia Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
SciNeuro is funded by 2 investors.
ARCH Venture Partners
and Lilly Asia Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
ARCH Venture Partners
|
Yes | Series A |
|
Lilly Asia Ventures
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
